Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel
Key Highlights
- ➤New Category I CPT codes approved for Inspire V (INSP) implantation
- ➤New CPT codes take effect January 1, 2028
- ➤CMS valuation process expected to publish proposed values in July 2027
- ➤CMS final CPT code valuations expected in November 2027
Expert Statements
Tim Herbert, Chairman and Chief Executive Officer of Inspire Medical Systems
“This new CPT code language addresses the implantation of a single lead and an implantable pulse generator (IPG) including our recently launched Inspire V system.”
Tim Herbert, Chairman and Chief Executive Officer of Inspire Medical Systems
“We appreciate the AMA creating dedicated codes that will create a clearer, more consistent path for coding and reimbursement, which we expect will reduce administrative burden for hospitals and physicians and support continued growth in patient access to Inspire therapy.”
MINNEAPOLIS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced that the American Medical Association (AMA) CPT(®) Editorial Panel has approved the establishment of a new set of Current Procedural Terminology (CPT(®)) codes that accurately describe and include the Inspire V system. The new Category I codes are scheduled to take effect on January 1, 2028.
“This new CPT code language addresses the implantation of a single lead and an implantable pulse generator (IPG) including our recently launched Inspire V system,” said Tim Herbert, Chairman and Chief Executive Officer of Inspire Medical Systems. “We appreciate the AMA creating dedicated codes that will create a clearer, more consistent path for coding and reimbursement, which we expect will reduce administrative burden for hospitals and physicians and support continued growth in patient access to Inspire therapy. The application received broad society support with special thanks to the American Academy of Otolaryngology-Head and the Neck Surgery (AAO-HNS), the American Academy of Sleep Medicine (AASM) and the International Surgical Sleep Society (ISSS) for their support addressing the need to act now to provide a permanent coding solution for the Inspire V system and other single lead hypoglossal nerve stimulation IPG therapies.”
Get started
Create a free account to read the full story.